Private Advisor Group’s Privia Health PRVA Stock Holding History

Private Advisor Group’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,678	Closed	-$427K	–	2080
2022 Q2	$427K	Buy	+14,678	New	+$373K	﹤0.01%	1480

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Private Advisor Group's PRVA Position: Q3 2022 in Review

Private Advisor Group sold out of Privia Health (PRVA) in Q3 2022, closing a stake of 14,678 shares — an estimated $427K sold.

Private Advisor Group first reported a position in PRVA in Q2 2022 and held it in 1 quarter. The position peaked at $427K in Q2 2022. 203 funds tracked by Wall St. Rank hold PRVA as of Q3 2022.

Private Advisor Group reported no remaining Privia Health position as of Q3 2022 after selling out during the quarter.
Private Advisor Group sold 14,678 Privia Health shares in Q3 2022, an estimated $427K.
Private Advisor Group first reported a position in Privia Health in Q2 2022 and held it in 1 quarter.
Private Advisor Group's Privia Health position peaked at $427K in Q2 2022.
203 funds tracked by Wall St. Rank held Privia Health as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.